---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-020715"
form_type: "8-K"
ticker: "VXRT"
cik: "0000072444"
company_name: "Vaxart, Inc."
filed_at: "2021-08-23T23:59:59+00:00"
generated_at: "2026-06-29T08:31:21.166066+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vaxart appoints Julie M. Cherrington, Ph.D. to Board of Directors

## Summary
- Dr. Cherrington appointed to Vaxart's Board and Audit Committee effective August 20, 2021.
- She receives annual cash retainers: $40k for Board, $7.5k for Audit Committee, plus time-based stock option for 65,700 shares vesting over 3 years.
- Dr. Cherrington is CEO of QUE Oncology, has held leadership roles at Gilead, SUGEN, and several oncology biotechs.
- Vaxart is developing oral tablet vaccines for COVID-19 and norovirus; Phase II COVID-19 trials expected.

## SEC filing metadata
- accession: 0001437749-21-020715
- form_type: 8-K
- ticker: VXRT
- cik: 0000072444
- company_name: Vaxart, Inc.
- filed_at: 2021-08-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/72444/000143774921020715/0001437749-21-020715-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/72444/000143774921020715/vxrt20210820_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-020715
- JSON: https://secwatch.observer/filing/0001437749-21-020715.json
- Plain text: https://secwatch.observer/filing/0001437749-21-020715.txt

## Key facts
- Executive change
  Julie M. Cherrington was appointed as Director at Vaxart, Inc..
  - Action: appointed
  - Role: Director
  source text: On August 20, 2021, the Board of Directors (the “ Board ”) of Vaxart, Inc. (the “ Company ”) appointed Julie M. Cherrington, Ph.D., to serve on our Board until her successor is elected and qualified, or sooner in the event of her death, resignation, or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/72444/000143774921020715/0001437749-21-020715-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.